Becker's Healthcare January 22, 2020
S&P Global Ratings released a report Jan. 21 detailing its predictions for the pharmacy benefit manager industry in 2020.
The financial services corporation said it has a negative outlook for the PBM industry this year, particularly for smaller, subscale PBMs.
Four key takeaways from the report:
- The risk for legislation that could hinder the PBM industry is significantly reduced in 2020, because it is an election year, according to the agency.
- S&P doesn’t expect proposals that would ban rebates — the discounts drugmakers pay to PBMs — to return anytime...